Ethnic differences in hypertension and blood pressure control in the UK

QJM: An International Journal of Medicine

Volumn 94, Issue 7, 2001, Pages 391-396

  Lane, D A ^a   Lip, G Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; POTASSIUM ION; RENIN; SODIUM ION;

ADOLESCENT; ADULT; AGED; ASIAN; AWARENESS; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CAUCASIAN; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONTROLLED CLINICAL TRIAL; DEATH; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG TOLERABILITY; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NEGRO; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; STROKE; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; VASCULAR RESISTANCE;

EID: 0034939022     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/94.7.391     Document Type: Note

References (29)

1. Heart attack, stroke, diabetes, and hypertension in West Indians, Asians and whites in Birmingham, England
2. Ethnicity and variations in mortality from coronary heart disease
3. Variations in mortality from diabetes mellitus, hypertension and renal disease in England and Wales by country of birth
4. Ethnic group comparisons of variables associated with ischaemic heart disease
5. Similarity of blood pressure in black, white and Asians in England: The Birmingham factory study
6. Blood pressure, smoking, obesity and alcohol consumption in black and white patients in general practice
7. Diabetes, hyperinsulinaemia, and coronary risk factors in Bangladeshis in East London
8. Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure
9. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians
10. Resting and ambulatory blood pressure differences in Afro-Caribbeans and Europeans
11. Ethnic differences in risk markers for heart disease in Bradford and implications for preventive strategies
12. Prevalence, detection and management of cardiovascular risk factors in different ethnic groups in south London
13. Differences in biological risk factors for cardiovascular disease between three ethnic groups in the Whitehall II study
14. Blood pressure levels and hypertension status among ethnic groups in England
15. Blood pressure studies in 14 communities: A two-stage screen for hypertension
16. National High Blood Pressure Education Program Working Group report on primary prevention of hypertension
17. Hypertension awareness, treatment and control in the community: Is the 'rule of halves' still valid?
18. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: Data from the health examination surveys, 1960 to 1991
19. Blood pressure screening, management and control in England: Results from the health survey for England 1994
20. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension
21. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo
22. The management of hypertensive disease in black patients
23. Comparison of propanalol and hydrochlorthiazide for the initial treatment of hypertension: I. Results of short-term titration with emphasis on racial differences in response
24. Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertension
25. Efficacy of nadolol alone and combined with bendroflumethiazide and hydralazine for systemic hypertension
26. Racial differences in response to low-dose captopril are abolished by the addition of hydrochlorthiazide
27. The efficacy and safety of valsartan compared with placebo in the treatment of patients with essential hypertension
28. The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020